Opportunities for collaboration with Office of the Principal Scientific Adviser, Government of India on Industry led Science & Technologies Cluster development
Initiatives taken by the Office of the Principal Scientific Adviser to the Government of India on COVID-19
Prof. K. VijayRaghavan, PSA, opines the COVID 19 vaccine results from Pfizer+BioNTech opens the closed door to vaccine availability a little.
Science & Technology efforts to mitigate COVID-19 by the Office of the Principal Scientific Adviser of India.
Uniting India's Voice for a better future for our human and environmental ecosystems.
Our Social Media Presence